For the patient who likes fewer clinic visits and consistent drug levels, semaglutide is the easier choice
Expected metabolic improvements Weight loss from semaglutide typically produces favorable changes in fasting glucose (decreases), HbA1c (decreases), triglycerides (decreases), LDL cholesterol (modest decrease), HDL cholesterol (modest increase), blood pressure (decreases with weight loss), and inflammatory markers like C-reactive protein (decreases)
Exercise, protein intake, sleep quality, and stress management all become critical factors in continued progress
Study characteristics Characteristics of the included studies are presented in Table 1
So far, Semaglutide has shown limited efficacy in controlling blood sugar levels and promoting weight loss in a small population of type 2 diabetes patients
Manufactured by Novo Nordisk, semaglutide acts as an agonist at the GLP-1 receptor to mimic the action of a natural hormone, glucagon-like peptide-1